← Evidence map

ArticleFrontiers in neurology2016

Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine.

Arjan Blokland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27746762